Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
Toevoeging PKC412 bij behandeling AML met FLT3-mutatie verlengt overall survival
sep 2017 | Leukemie